Results 11 to 20 of about 1,718,268 (213)

Epidemiology and factors associated with Extra-pulmonary tuberculosis in a Low-prevalence area

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023
Background Tuberculosis is a global public health problem. Extra-pulmonary tuberculosis accounts for an increasing proportion of cases worldwide, although information about epidemiological, clinical, or microbiological factors is lacking.
M. Rolo, B. González-Blanco, C. Reyes, N. Rosillo, P. López-Roa   +4 more
semanticscholar   +1 more source

Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.

Lancet Global Health, 2022
BACKGROUND BCG vaccines are given to more than 100 million children every year, but there is considerable debate regarding the effectiveness of BCG vaccination in preventing tuberculosis and death, particularly among older children and adults.
L. Martinez, Olivia Cords, Qiao Liu, C. Acuña-Villaorduña, Maryline Bonnet, G. J. Fox, A. C. Carvalho, P. Chan, J. Croda, P. Hill, E. López-Varela, S. Donkor, K. Fielding, S. Graham, M. Espinal, B. Kampmann, A. Reingold, H. Huerga, J. Villalba, L. Grandjean, G. Sotgiu, U. Egere, Sarman Singh, Limei Zhu, C. Lienhardt, J. Denholm, J. Seddon, C. Whalen, A. García-Basteiro, R. Triasih, Cheng Chen, Jitendra Singh, Li-Min Huang, Surendra K. Sharma, D. Hannoun, H. Del Corral, A. Mandalakas, LaShaunda L. Malone, D. Ling, A. Kritski, Catherine M. Stein, R. Vashishtha, F. Boulahbal, C. Fang, W. Boom, E. Netto, A. C. Lemos, A. Hesseling, A. Kay, E. Jones-López, C. Horsburgh, C. Lange, J. Andrews   +52 more
semanticscholar   +1 more source

Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017–19: a multistage, cluster-based, cross-sectional survey

Lancet. Infectious Diseases (Print), 2022
Summary Background Tuberculosis remains an important clinical and public health issue in South Africa, which has one of the highest tuberculosis burdens in the world.
S. Moyo, F. Ismail, M. L. van der Walt, N. Ismail, Nkateko Mkhondo, Sicelo B Dlamini, T. Mthiyane, J. Chikovore, Olanrewaju Oladimeji, D. Mametja, Phaleng Maribe, I. Seocharan, Phumlani Ximiya, I. Law, M. Tadolini, K. Zuma, S. Manda, C. Sismanidis, Y. Pillay, L. Mvusi   +19 more
semanticscholar   +1 more source

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Cochrane Database of Systematic Reviews, 2021
Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and rifampicin resistance in people with signs and symptoms of tuberculosis.
J. S. Zifodya, J. Kreniske, I. Schiller, Mikashmi Kohli, N. Dendukuri, S. Schumacher, E. Ochodo, F. Haraka, A. Zwerling, M. Pai, K. Steingart, D. Horne   +11 more
semanticscholar   +1 more source

Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis

PLoS ONE, 2021
Objective The proportion of COVID-19 patients having active pulmonary tuberculosis, and its impact on COVID-19 related patient outcomes, is not clear.
A. Aggarwal, R. Agarwal, S. Dhooria, K. Prasad, I. Sehgal, V. Muthu   +5 more
semanticscholar   +1 more source

Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis

Pulmonary Medicine, 2021
Introduction Vitamin D has a significant role in host immune defense against Mycobacterium tuberculosis. It has been suggested that pulmonary tuberculosis may be associated with lower levels of vitamin D.
Vijay Jaimni, Barkur Ananthakrishna Shasty, Sharath P. Madhyastha, G. Shetty, R. Acharya, R. Bekur, Akhila Doddamani   +6 more
semanticscholar   +1 more source

Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae

European Respiratory Journal, 2019
We read with interest the study reported by Collin et al. [1], who carried out a survey on organisation and priorities of national tuberculosis (TB) programmes in Europe. With an estimated annual incidence of 10 million cases, TB is considered one of the
D. Visca, E. Zampogna, G. Sotgiu, R. Centis, L. Saderi, L. D’Ambrosio, V. Pegoraro, P. Pignatti, M. Muñoz-Torrico, G. Migliori, A. Spanevello   +10 more
semanticscholar   +1 more source

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.

New England Journal of Medicine, 2020
BACKGROUND Patients with highly drug-resistant forms of tuberculosis have limited treatment options and historically have had poor outcomes. METHODS In an open-label, single-group study in which follow-up is ongoing at three South African sites, we ...
M. Bolhuis, T. S. van der Werf, O. Akkerman   +2 more
semanticscholar   +1 more source

Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing

BMC Infectious Diseases, 2017
Background Emergence of multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB) is a major hurdle for TB control programs especially in developing countries like China. Resistance to fluoroquinolones is high among MDR-TB patients.
Jun Chen, Peng Peng, Yixiang Du, Yi Ren, Lifeng Chen, Youyi Rao, Weihua Wang   +6 more
doaj   +1 more source

Risk factors for microbiological persistence after 6 months of treatment for Mycobacterium intracellulare and its impact on the drug-resistance profile

Microbiology Spectrum, 2023
Patients with Mycobacterium intracellulare pulmonary disease are more likely to experience poor treatment outcomes if they have been observed with microbiological persistence after 6 months of treatment.
Xuejiao Luo, Xubin Zheng, Yong Fang, Fangyou Yu, Haiyan Cui, Qin Sun, Wei Sha   +6 more
doaj   +1 more source